Cipla to market MSD's HIV drug 'raltegravir' in India

MSD in India Managing Director K G Ananthakrishnan said the partnership is aligned with the company's commitment towards patients in India.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news